Molson Coors Beverage Company logo

Molson Coors Beverage Company (TAP)

Market Closed
21 Jul, 20:00
NYSE NYSE
$
40. 86
-0.75
-1.8025%
After Hours
$
41. 39
+0.53 +1.2971%
7.8B Market Cap
14.76 P/E Ratio
1.92% Div Yield
2.1M Volume
5.67 Eps
$ 41.61
Previous Close
Add Transaction
Day Range
40.63 41.62
Year Range
38.04 54.82
Want to track TAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?

Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?

Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Molson Coors Rises 7% in 6 Months: Should You Buy, Hold or Avoid?

Molson Coors Rises 7% in 6 Months: Should You Buy, Hold or Avoid?

TAP makes significant progress against the Acceleration Plan. It is focused on portfolio premiumization as well.

Zacks | 1 year ago
Why Molson Coors Brewing (TAP) is a Top Value Stock for the Long-Term

Why Molson Coors Brewing (TAP) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Molson Coors Trades Below 200 & 50-Day SMA: How to Play the Stock

Molson Coors Trades Below 200 & 50-Day SMA: How to Play the Stock

TAP's revitalization plan shows resilience amid U.S. pressures, with strong earnings growth and promising global expansion.

Zacks | 1 year ago
U.S. surgeon general calls for cancer risk warnings on alcohol labels

U.S. surgeon general calls for cancer risk warnings on alcohol labels

The U.S. surgeon general on Friday issued a new advisory warning about the link between alcohol consumption and increased cancer risk. Surgeon General Dr. Vivek Murthy called additions to labels warning of the connection between alcohol use and cancer risk.

Cnbc | 1 year ago
Trump's Beer Tariffs Cloud Sector: Molson Coors Is Well Positioned, But This Is The 'Best Company In The Beverage Space,' Says Analyst

Trump's Beer Tariffs Cloud Sector: Molson Coors Is Well Positioned, But This Is The 'Best Company In The Beverage Space,' Says Analyst

Following sluggishness during the summer months, trends in the U.S. beer market are showing signs of improvement, according to Needham.

Benzinga | 1 year ago
Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Molson Coors Low P/E Valuation Looks Attractive: Time to Buy or Wait?

Molson Coors Low P/E Valuation Looks Attractive: Time to Buy or Wait?

TAP's revitalization plan, premiumization and promising global expansion show resilience. However, challenges in the United States raise concerns.

Zacks | 1 year ago
Here's Why Molson Coors Brewing (TAP) is a Strong Momentum Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Molson Coors Rises 5% Post Q3 Earnings: Buy, Hold or Avoid the Stock?

Molson Coors Rises 5% Post Q3 Earnings: Buy, Hold or Avoid the Stock?

TAP makes significant progress with the Acceleration Plan. The company's revitalization plan and the premiumization of the global portfolio also bode well.

Zacks | 1 year ago
Loading...
Load More